TRIDENT LIFELINE
|
The Current P/E Ratio of TRIDENT LIFELINE is 28.40.
Share Price | ₹150.5 | May 31,2024 |
Market Cap | ₹173.1 Cr | |
Earnings-TTM | ₹6.1 Cr | TTM-Consolidated Results |
Price/Earnings | 28.40x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of TRIDENT LIFELINE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹173.1 Cr] as on May 31,2024
(/) Earnings [ ₹6.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 28.40x ]
Thus, for TRIDENT LIFELINE , the investors are currently willing to pay 28.40 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TRIDENT LIFELINE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of TRIDENT LIFELINE over the last five years.
Historical PE (Price/Earnings) ratio chart of TRIDENT LIFELINE
PE Ratio Performance Analysis for TRIDENT LIFELINE
- TRIDENT LIFELINE 's p/e ratio for fiscal years ending Mar2023 to Mar2022 averaged 15.21x.
- TRIDENT LIFELINE 's operated at median p/e ratio of 30.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, TRIDENT LIFELINE 's p/e ratio peaked in Mar2023 at 30.41x.
- TRIDENT LIFELINE 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does TRIDENT LIFELINE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
TRIDENT LIFELINE | 6.10 | 28.40 | 173.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 9,648.44 | 36.31 | 350,339.0 |
CIPLA LTD | 4,155.31 | 28.14 | 116,930.0 |
DR REDDYS LABORATORIES LTD | 5,563.20 | 17.35 | 96,546.9 |
ZYDUS LIFESCIENCES LTD | 3,831.40 | 26.28 | 100,694.0 |
DIVIS LABORATORIES LTD | 1,600.00 | 71.51 | 114,416.0 |
MANKIND PHARMA LTD | 1,926.55 | 44.63 | 85,978.3 |
TORRENT PHARMACEUTICALS LTD | 1,656.00 | 55.11 | 91,258.4 |
LUPIN LTD | 1,935.57 | 37.40 | 72,388.0 |
AUROBINDO PHARMA LTD | 3,186.13 | 21.83 | 69,550.9 |
ABBOTT INDIA LTD | 1,201.22 | 45.77 | 54,984.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TRIDENT LIFELINE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.35x |
Max industry PE | 71.51x |
Median industry PE | 36.31x |
Average industry PE | 37.52x |
You may also like the below Video Courses